Emilce Vega

Corporate Legal Director (global Corporate Development) at Acino

Emilce Vega has a diverse work experience spanning various industries and roles. Emilce currently serves as the Corporate Legal Director at Acino, focusing on corporate development and cross-border transactions. Prior to that, they were the Head of Legal at Drugs for Neglected Diseases Initiative (DNDi), overseeing legal matters related to global strategy and operations. Emilce also worked as the Deputy General Counsel at Inventages Venture Capital and a Senior Associate at Shepherd and Wedderburn, specializing in media and technology. Additionally, they gained experience as a Legal Counsel at Teva Pharmaceuticals and had private practice experience. Overall, Emilce Vega has a strong background in corporate law and has worked in both legal advisory roles and in-house positions.

Emilce Vega has a diverse education history. Emilce completed a Postgraduate Diploma in Legal Practice with a focus on Banking, Corporate, Finance & Commercial Law at BPP Law School from 2000 to 2001. Prior to that, they obtained a Post-graduate Diploma in Law from the same institution from 1999 to 2000. Emilce pursued their passion for Molecular Genetics by earning a Post-Graduate Research degree from the University of Oxford from 1995 to 1999. Emilce also holds a Master of Science degree in Molecular Genetics from the University of Leicester, which they obtained from 1994 to 1995. Their undergraduate studies were focused on Genetics, which they pursued at Universidad Nacional de Misiones / Leicester University, earning a Bachelor of Science degree from 1988 to 1993. In addition to their academic qualifications, they have obtained Certificates on Team Management & Strategic Planning and Execution from Harvard Business School Online.

Links

Previous companies

Teva Pharmaceutical Industries logo

Timeline

  • Corporate Legal Director (global Corporate Development)

    September, 2021 - present

A panel showing how The Org can help with contacting the right person.